Diabetes, Heart and Cardiovascular Diseases News Chronicle Diabetes, Cardiovascular and Heart Diseases. Article 35
Published on August 1, 2016 at 11:05 AM


About PolyNovo
PolyNovo Limited (formerly Calzada limited), Melbourne Australia based company partnered with Prof Toby Coates and Prof John Greenwood to find alternative technology to islet cell transplantation for the treatment individuals with type 1 diabetes (T1D).

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Risks With High BMI

 

Benefits With Brisk Walk

A study by Duke University School of Medicine shows brisk walk is more effective compared with jogging in reducing blood glucose levels in prediabetes individuals. They says high intensity exercise burns more glucose and moderate intensity exercise burns more fat. Brisk walk of 11.5 miles per week is better than 11.5 miles of jogging for prediabetes individuals. Lead author of the study is Dr William Kraus, M.D and study findings were published in the journal Diabetologia.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Device To Release Drugs In Eye
2. Benefits With Alcohol Free Blueberry Blackberry Wine
3. Study Of Liraglutide Drug On Heart Failure

 

About Beta Cell 'Hubs'

Study done Dr David Hodson, University of Birmingham says 65% to 80% of islet cells are of beta cells. Study found that just 1 to 10% of beta cells control islet response to blood glucose. Failure of this few cells lead to diabetes. Studies are conducted in mice, rat and human models. Study findings were published in Cell Metabolism.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Transplanting Laboratory Grown Beta Cells
2. Risks With Fine Dust
3. Risks With Heart Attack

 

Benefits With Breast Feeding

Study done by researchers from Helmholtz Zentrum Muenchen Germany says women with gestational diabetes (GD) after pregnancy can protect themselves against development of type 2 diabetes (T2D) by breast feeding for more than three months. The three months breast feeding will bring long term metabolic changes and gets protection from type 2 diabetes (T2D) for at least 15 years.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. SR10171 Drug For The Treatment Of Bone Disease And Diabetes
2. About Coronary Heart Disease (CHD)

 

Diabetes Gender Specific Factors

Gender is not consider a factor in the international guidelines for the management of type 2 diabetes (T2D). A study done by Alexandra Kautzky-Willer, Medical University of Vienna, Austria says diabetes treatment should be gender specific as risk factors and their effects on type 2 diabetes (T2D) individuals are different with respect to men and women. Researchers says gender specific factors should be incorporated in the international guidelines for the management of diabetes mellitus. The differences are

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Risks To Diabetes Induced Cognitive Impairment
2. Risks With Heart Disease

 

Risk With Teenage Obesity
A study done by researchers from Sheba Medical Center, Israel found that obesity during teenage are at five fold death risk from coronary heart disease, three fold death risk from cardiovascular causes and two fold death risk from stroke during later in life. Study findings were published in New England Journal of Medicine on Apr 13, 2016.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Biomarkers To Childhood Obesity
2. Risks With Adrenal Tumors NFATs

 

Approval Of Synjardy Drug
FDA approved synjardy drug that improves glycemic control in adults with type 2 diabetes (T2D). Synjardy is a single pill combination drug containing empagliflozin and metformin hydrochloride. The drug reduced A1C levels significantly after 24 weeks. The most common side affects of the drug are nausea, vomit and tiredness.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Risks With Statins Pills

 

About Qtern Drug
Qtern with metformin combination shows significant reduction in HbA1c when compared with other combination drugs. The European Commission gave nod for the drug in all 28 member countries and Iceland.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Device To Predict Diabetes
2. Benefits With Coffee Consumption
3. Risks To Heart Attack And Diabetes Before Menopause

 

Categories

Sitemap 1   Sitemap 2   Sitemap 3   Sitemap 4

 

Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.


Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.